Erluo Chen

51 papers receiving 6.3k citations

Erluo Chen's Hit Papers

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial 2019 · 1.3k citations
1.3k0+10+21Years since publication4008001.2k

Peers

Erluo Chen
Comparison fields: 5 of 135
  • Internal Medicine 1.0k
  • Hepatology 1.0k
  • Obstetrics and Gynecology 674
  • Orthopedics and Sports Medicine 753
  • Pathology and Forensic Medicine 1.1k
Replace Catherine Stehman‐Breen with:
Catherine Stehman‐Breen United States
M. Greaves United Kingdom
Tanya M. Petterson United States
Armando D’Angelo Italy
Paolo Simioni Italy
Catherine Nelson‐Piercy United Kingdom
Takashi Akiba Japan
Adam Torbicki Poland
Wendy Lim Canada
C. Gregory Elliott United States
Erluo Chen relative to Catherine Stehman‐Breen United States Catherine Stehman‐Breen's profile →
Citations per field
00.5×5.7×
Catherine Stehman‐Breen · 1×
Citations per year

Countries citing papers authored by Erluo Chen

Since Specialization
Citations

This map shows the geographic impact of Erluo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erluo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erluo Chen more than expected).

Fields of papers citing papers by Erluo Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erluo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erluo Chen. The network helps show where Erluo Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Erluo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erluo Chen Line = papers co-authored together Erluo Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Hit paper breakdown →
20191329
2
A Prospective Study of Venous Thromboembolism after Major Trauma
Hit paper breakdown →
19941031
3
Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy
Hit paper breakdown →
2005697
4
A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major Trauma
Hit paper breakdown →
1996586
5 1995383
6 2005261
7 1992257
8 1997227
9 2005216
10 1997200
11 2019159
12 2004132
13 1992107
14 2006105
15 201993
16 200783
17 199475
18 199870
19 199567
20 200265

About Erluo Chen

Erluo Chen is a scholar working on Orthopedics and Sports Medicine, Oncology, Obstetrics and Gynecology, Surgery and Pathology and Forensic Medicine, having authored 52 papers that have together received 6.7k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (10 papers), Gestational Diabetes Research and Management (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Bone health and treatments (5 papers), Bone Metabolism and Diseases (3 papers), Vitamin D Research Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Vitamin C and Antioxidants Research (2 papers). The work is most often cited by research in Internal Medicine (1.0k citations), Hepatology (1.0k citations), Obstetrics and Gynecology (674 citations), Orthopedics and Sports Medicine (753 citations) and Pathology and Forensic Medicine (1.1k citations). Erluo Chen has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include C. David Naylor, William Geerts, Anne E. de Papp, Richard A. Petruschke, Neil Binkley, Mary K. Beard, Michael F. Holick, Ethel S. Siris, Aliya Khan and Mathew Sermer. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism, New England Journal of Medicine, American Journal of Obstetrics and Gynecology and Obstetrical & Gynecological Survey.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact